These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. Jeng BH; Galor A; Lee MS; Meisler DM; Hollyfield JG; Schoenfield L; McMahon JT; Langston RH Ophthalmology; 2008 Sep; 115(9):1540-4. PubMed ID: 18501429 [TBL] [Abstract][Full Text] [Related]
3. Reversible amantadine-induced corneal edema in an adolescent. Hughes B; Feiz V; Flynn SB; Brodsky MC Cornea; 2004 Nov; 23(8):823-4. PubMed ID: 15502485 [TBL] [Abstract][Full Text] [Related]
4. Bilateral corneal edema secondary to amantadine in the pediatric population: a case report. Santiago-Cabán LA; Rivera E; López-Beauchamp V Bol Asoc Med P R; 2012; 104(1):69-76. PubMed ID: 22788084 [TBL] [Abstract][Full Text] [Related]
5. Sudden onset of amantadine-induced reversible bilateral corneal edema in an elderly patient: case report and literature review. Hotehama A; Mimura T; Usui T; Kawashima H; Amano S Jpn J Ophthalmol; 2011 Jan; 55(1):71-4. PubMed ID: 21331699 [No Abstract] [Full Text] [Related]
16. Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration. French DD; Margo CE Cornea; 2007 Oct; 26(9):1087-9. PubMed ID: 17893540 [TBL] [Abstract][Full Text] [Related]